ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,641Medicare Part D Prescriptions Filled, Including Refills

Rank: 686 out of 3647

$770K Total Retail Price of All Prescriptions

Rank: 456 out of 3647

407 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 407 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 407 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 6,775 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 549 330 1 2
CRESTOR 413 233 2 19
INDAPAMIDE 386 240 3 296
METFORMIN HCL 362 194 4 6
OMEPRAZOLE 345 210 5 3
HYDROCODONE-ACETAMINOPHEN 341 175 S3 6 12
LISINOPRIL 317 161 7 4
AMLODIPINE BESYLATE-BENAZEPRIL 309 245 8 74
PRAVASTATIN SODIUM 293 220 9 16
POTASSIUM CHLORIDE 277 206 10 24
FUROSEMIDE 252 165 11 8
IBUPROFEN 237 121 12 55
METOPROLOL TARTRATE 224 146 13 7
TRAMADOL HCL 217 84 14 22
WARFARIN SODIUM 209 118 15 15
NEXIUM 174 98 16 44
ALLOPURINOL 172 141 17 37
ALENDRONATE SODIUM 158 125 18 23
DIOVAN 152 97 19 40
ZOLPIDEM TARTRATE 143 68 20 14
EXFORGE 139 85 21 198
GLIMEPIRIDE 133 59 22 45
HYDROCHLOROTHIAZIDE 129 52 23 9
CARVEDILOL 126 96 24 20
LANTUS 120 81 25 59
RANITIDINE HCL 119 82 26 29
CYCLOBENZAPRINE HCL 118 62 R 27 98
CLOPIDOGREL 114 71 28 26
KLOR-CON M20 109 69 29 121
PROAIR HFA 108 35 30 62
ATORVASTATIN CALCIUM 108 83 30 13
SIMVASTATIN 107 64 32 1
MELOXICAM 107 76 32 33
DIOVAN HCT 105 36 34 80
LANTUS SOLOSTAR 101 59 35 124
PLAVIX 101 68 35 39
METFORMIN HCL ER 99 69 37 92
JANUVIA 97 75 38 72
CLONIDINE HCL 90 39 39 46
ONGLYZA 82 48 40 238
LEVEMIR FLEXPEN 78 46 41 246
TIZANIDINE HCL 75 21 42 126
DOXAZOSIN MESYLATE 69 55 43 57
PEN NEEDLE 66 35 44 166
LYRICA 66 32 44 120
SERTRALINE HCL 63 18 46 27
BENICAR HCT 62 49 47 165
INSULIN SYRINGE 61 45 48 76
SULFAMETHOXAZOLE-TRIMETHOPRIM 61 32 48 110
GABAPENTIN 60 20 50 17
LANSOPRAZOLE 59 24 51 116
LEVOTHYROXINE SODIUM 56 37 52 5
METOCLOPRAMIDE HCL 55 53 53 135
AMITRIPTYLINE HCL 54 0 R 54 105
DIGOXIN 51 29 55 51
METOPROLOL SUCCINATE 51 0 55 18
ADVAIR DISKUS 50 21 57 52
ACETAMINOPHEN-CODEINE 50 39 S3 57 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.